Minimus Spine is developing ozone injection technology —TrioJection syringe cartridge — for the treatment of spinal disorders related to herniated discs. The company will use the TETF award for the commercialization of the technology. The company is working with Texas A&M University in College Station on the technology, according to the report.
More Articles on Spine:
Robotics in Spine Surgery: Pros, Cons & Whether it Makes Sense to Adopt Today
5 Spine & Neurosurgeons in New Leadership Positions
Bundled Payments for Spine Surgery: What’s On the Horizon
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
